Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raux

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
AIDS Research and Human Retroviruses|May 20, 1999
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le SidaD Salmon-Céron, J L Excler, L Finkielsztejn, et al.
Epidemiology and Infection|December 16, 2000
The seroepidemiology of rubella in western EuropeR G Pebody, W J Edmunds, M Conyn-van Spaendonck, et al.
Epidemiology and Infection|November 1, 2000
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubellaN Andrews, R G Pebody, G Berbers, et al.
Epidemiology and Infection|May 15, 2001
The seroepidemiology of measles in Western EuropeH de Melker, R G Pebody, W J Edmunds, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
AIDS Research and Human Retroviruses|May 20, 1999
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le SidaD Salmon-Céron, J L Excler, L Finkielsztejn, et al.
Epidemiology and Infection|December 16, 2000
The seroepidemiology of rubella in western EuropeR G Pebody, W J Edmunds, M Conyn-van Spaendonck, et al.
Epidemiology and Infection|November 1, 2000
The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubellaN Andrews, R G Pebody, G Berbers, et al.
Epidemiology and Infection|May 15, 2001
The seroepidemiology of measles in Western EuropeH de Melker, R G Pebody, W J Edmunds, et al.
Pageof 5